Drugs / pomegranate polyphenol extract
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01102140 Comparator | Jul 2010 → May 2013 | cardiomyopathy, heart failure | Jennifer Cowger , MD, MS | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pomegranate polyphenol extract | “POMx, pomegranate polyphenol extract” NCT01102140 ↗ |
| Known as | POMx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01102140 ↗ |
| Route | Oral | “1000 mg orally once daily.” NCT01102140 ↗ |